INTRODUCTION
============

Silent information regulator proteins (Sirtuins / SIRTs) are nicotinamide adenine dinucleotide (NAD^+^)-dependent class III histone deacetylases (HDACs), which are linked to the damage occurring in neurodegenerative diseases \[[@b1-en-28-537]\]. They play key roles in mood disorders \[[@b2-en-28-537]\], and abnormal functioning of SIRT1 mediates depression-like behavior in the nucleus accumbens and hippocampus of rodents \[[@b3-en-28-537], [@b4-en-28-537]\]. However, the function of SIRT2 and its role in depression remain controversial. *SIRT2* mRNA is decreased in the peripheral white blood cells of patients with major depressive disorder (MDD) or bipolar disorder (BPD) \[[@b5-en-28-537]\], and SIRT2 overexpression in the hippocampus of mice promotes neurogenesis and reverses chronic unpredictable stress (CUS)-induced depressive-like behaviors \[[@b6-en-28-537]\]. Also SIRT2 expression is increased in the prefrontal cortex of depressed patients and an animal model of chronic social defeat stress \[[@b7-en-28-537]\]. These studies suggest that SIRT2 is involved in the development of depression. However little is known about how SIRT2 regulates stress responses at the molecular level in the hippocampus, which is the region susceptible to environmental stress.

Susceptibility or resilience to stress appears to be regulated by epigenetic mechanisms including histone modification \[[@b8-en-28-537]\]. Class I and II HDACs are involved in the behavioral response to chronic stress and antidepressants in rodents, suggesting the possibility of using HDAC inhibitors in patients with treatment-resistant depression \[[@b9-en-28-537]\]. Methylation of histones is an additional epigenetic mechanism involved in depression \[[@b10-en-28-537]\]. Chronic stress induces the expression of euchromatic histone-lysine N-methyltransferase 2 (Ehmt2) involved in complexes repressing transcription \[[@b11-en-28-537]\]. Ehmt2-induced di-methylated histone 3 lysine 9 (H3K9me2) is a marker of repression induced in the hippocampus and amygdala during stress and anxiety \[[@b11-en-28-537]\]. Although Ehmt2 mediates stress-induced depression-like behaviors \[[@b11-en-28-537]\], the associated transcriptional program is poorly understood.

Here we demonstrate that chronic stress-induced downregulation of SIRT2 increases expression of histone methyltransferases in the hippocampus of a mouse depression model, resulting in transcriptional repression of synaptic plasticity-related genes. Furthermore, knockdown of SIRT2 in the dentate gyrus (DG) precipitated depression-like behaviors in mice, accompanied by reduced expression of synaptic plasticity-related genes. These observations reveal a molecular mechanism that explains why hippocampal SIRT2 expression in depressive state impairs synaptic plasticity, and underline the importance of SIRT2 as a potential target for protecting synapses from depression.

MATERIALS AND METHODS
=====================

Mice
----

All experiments were conducted with 8--12-week-old male C57BL/6J mice (Charles River Korea, Seoul, Korea). The mice were housed 3--4 per cage in a temperature- and humidity-controlled environment under a 12-h light/dark cycle (lights on 07:00--19:00) with access to food and water ad libitum. All animals were handled in accordance with animal care guidelines of Hanyang University, and all animal experiments were approved by the Institutional Animal Care and Use Committee of Hanyang University (HY-IACUC-18-0055).

Culture of primary hippocampal neurons
--------------------------------------

Primary hippocampal neuronal were cultured as previously described \[[@b12-en-28-537]\].

Drugs
-----

For *in vitro* drug treatment, AGK2 (2-cyano-3-\[5-(2,5-dichlorophenyl)-2-furanyl\]-N-5-quinolinyl-2-propenamide, A8231, Sigma, MO, USA) was prepared as a 10 mM stock solution in dimethyl sulfoxide (DMSO) and diluted in fresh medium at a final concentration of 5 μM. Primary hippocampal neurons were treated with AGK2 for 72 h.

Chromatin immunoprecipitation assays (ChIP)
-------------------------------------------

ChIP assays were performed as previously described \[[@b12-en-28-537]\]. Mouse hippocampal tissue and cultured hippocampal neurons were chemically cross-linked by the addition of formaldehyde solution and then sonicated. The resulting extract was incubated with 5 μg of the appropriate antibody and Protein G Agarose beads (Roche, Mannheim, Germany). The antibodies used are anti-ΔFosB (Cell signaling, MA, USA, \#14695), anti-CoREST (Millipore, CA, USA, \#07-455) and anti-H3K9me2 (Cell signaling, MA, USA, \#4658). Immunoprecipitated DNA samples were resuspended in distilled H~2~O and used in real-time PCR (CFX96 TouchTM Real-Time PCR Detection System, Bio-Rad Laboratories, CA, USA), using the following primer pairs corresponding to mouse gene promoter regions: *Actb (Actin)*, 5′-GCCGCTGTGGCGTCCTATAA-3′ and 5′-TGAGGTACTAGCCACGAGAG-3′; *Sirt2*, 5′-GCACAAAAACCAGACCCAAA-3′ and 5′-TTGTACCCGGGATTTTCTTG-3′; *Ehmt2*, 5′-AGATGCCGAATTGGCCTT GG-3′ and 5′-TGCCTGTATGGTTGCTCACA-3′; *Scmh1*, 5′-TGGGTATTAGGGGG AAACTGTA-3′ and 5′-TAAGGTTGACAGAATCCTGGGC-3′; *Egr1*, 5′-CGCCTTA TATGGAGTGGCCC-3′ and 5′-AGGCTCCTGGAAAGCCTAGTA-3′; *Synaptophysin*, 5′-TGCCAACAAGACCGAGAGTG-3′ and 5′-TTCGGCTGACGAGGAGTAGT-3′; *Synapsin1*, 5′-CCAGCTCAACAAATCCCAGTC-3′ and 5′-GCGGATGGTCTCAGCT TTCA-3′. Primer sequences are shown in *below*. Promoter enrichment was assessed and normalized to the values obtained with the *Actin* promoter.

Immunohistochemistry and Western blot analysis
----------------------------------------------

Mice were perfused with 4% paraformaldehyde in PBS for 20 min and processed for histology. Immunofluorescence labeling and Western blot analysis were performed as previously described \[[@b12-en-28-537]\]. The primary antibodies used for immunohistochemistry and Western blot analysis were as follows: β-actin (Santa Cruz, sc-47778), ΔFosB (Cell signaling, \#14695), SIRT2 (Millipore, 09-843), Egr1 (Cell signaling, \#4153), Tuj1 (Covance, MMS-435P), GluR1 (Upstate, \# 06-306), GluR2 (Millipore, AB1768-I), NR1 (Upstate, \#06-311), PSD95 (abcam, ab18258), Synaptophysin (abcam, ab32127), Synapsin1 (Cell signaling, \#5297), CoREST (Millipore, \#07-455), and GFP (Roche Applied Sciences, 11 814 460 001).

Co-immunoprecipitation
----------------------

Hippocampal neuron lysates were generated by using lysis buffer (Cell Signaling, MA, USA) contained protease inhibitor and phosphatase inhibitor I and II (Sigma). 2 μg antibody (CoREST, Millipore, CA, USA, \#07-455) or rabbit IgG (Millipore, CA, USA) was added to lysates containing 500 μg protein at 4°C overnight \[[@b12-en-28-537]\], which was followed by immunoprecipitation with 30 μl Protein G Agarose beads (Roche, Mannheim, Germany). Beads were washed five times with HNTG buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.1% Triton X-100 and 10% glycerol). The bound proteins were eluted with 2X Laemmli sample buffer (126 mM Tris-HCl, 20% glycerol, 4% SDS, 0.02% bromophenol blue) and analyzed by Western blotting.

RT-PCR and qPCR
---------------

RNA was extracted from hippocampi with Trizol reagent (Sigma), and reverse transcribed with Improm-II (Promega, WI, USA), 1 μg of total RNA and oligonucleotide-dT primer. Quantitative real-time PCR (qPCR) was performed on a CFX96 Touch^TM^ Real-Time PCR Detection System (Bio-Rad Laboratories) using the primer sets of 5′-AGCCAACCATCTGCCACTAC-3′ and 5′-CCAGCCCATCGTGTA TTCTT-3′ for *Sirt2*, 5′-AGGCAGAGCTGGAGTCGGAGAT-3′ and 5′-GCCGAGGA CTTGAACTTCACTCG-3′ for *ΔFosB*, 5′-GACGAGTTATCCCAGCCAAA-3′ and 5′-GGCAGAGGAAGACGATGAAG-3′ for *Egr1*, 5′-CACCAGGATGAAGACAAGCA-3′ and 5′-GTCGTTGTTGAGCAGGAG-3′ for *Synapsin1*, 5′-TGCCAACAAGACGGA G-3′ and 5′-GGCGGATGAGCTAACT-3′ for *Synaptophysin*, 5′-TTCTTCAGCTCCA GGGACAT-3′ and 5′-AGAATCGGTCACCGTAGTCA-3′ for *Ehmt2*, and 5′-CACCT TGCTCTGACCTCTGAC-3′ and 5′-AATTCTAGCTGGATGGGAGTGA-3′ for *Scmh1*. Ct values for each sample were obtained using CFX Manager Software version 3.0 (Bio-Rad Laboratories). Gene expression was normalized to the amount of β*-actin* mRNA. Normalized expression values were averaged, and average fold changes were calculated.

Construction of a short hairpin RNA (shRNA)-expressing vector, and lentivirus production
----------------------------------------------------------------------------------------

For *Sirt2* gene silencing, XhoI-HpaI fragment including SIRT2 shRNA (shSIRT2; sense, 5′-TGCCTCTATGC A A AC C T G G AG A AT T C A AG AG AT T C T C C AG G TTTGCATAG AGGTTTTTTC-3′ and antisence, 5′-TCGAGAAAAAACCTCTATGCA AACCTGGA GAATCTCTTGAATTCTCCAGGTTTGCATAGAGGCA-3′) were annealed and cloned into pLB lentiviral vector (Addgene, \#11619) \[[@b13-en-28-537]\]. Luciferase shRNA (shLuc) as control vector was previously described \[[@b12-en-28-537]\]. The shSIRT2 plasmid was confirmed by DNA sequencing (Macrogen, Korea). Human embryonic kidney epithelial 293T cells (ATCC) were maintained in DMEM (Welgene, LM001-01) supplemented with 10% fetal bovine serum (JRS, 43640), 1% penicillin/streptomycin (Welgene, LS202-02) as growth media. 293T cells were transfected using the calcium phosphate method \[[@b14-en-28-537]\]. 2×10^6^ cells of 293T were seeded in 100 mm dish at 60\~70% confluence the day before transfection. To produce virus, 12 μg shSIRT2 or shLuc plasmids were transiently cotransfected with the compatible packaging plasmids, 8 μg psPAX2 (Addgene, \#12260) and 6 μg pMD2.G (Addgene, \#12259) into 293T cells using CaPO~4~-DNA precipitate method. After 12 h, the media was changed to DMEM growth medium supplemented with 20% BSA (Sigma, A7906) and 1M HEPES (Sigma, H3375). After 48 h post-transfection, the media was collected, centrifuged at 1,500 rpm 4°C for 5 min to remove cell debris, and sterilized using 0.45 μm low protein binding syringe filters (ADVANTEC, 25CS045AS). For virus concentration, collected lentiviral supernatant was added with 5X PEG solution (Sigma, P5413) and incubated for overnight at 4°C. Next day, the mixture was centrifuged at 3,000 rpm 4°C for 30 min and the pellet was incubated with 1X PBS containing 1% BSA on the shaker at 4°C. For virus transduction, concentrated virus involving 8 μg/ml protamine sulfate (Sigma, P4020) was transferred to in vivo or in vitro, and performed further experimental analysis.

Virus-mediated gene transfer
----------------------------

Mice were anesthetized with a mixture of ketamine (100 mg/ kg) and xylazine (10 mg/kg) and prepared for stereotaxic surgery. Thirty-three gauge syringe needles (Hamilton, NV, USA) were used to bilaterally infuse 3 μl of virus into the dorsal hippocampus at a rate of 0.1 μl/min at the stereotaxic coordinates −2.0 anteroposterior (AP), ±1.5 mediolateral (ML), −2.4 dorsoventral (DV) (mm from bregma, horizontal skull).

Chronic stress procedures
-------------------------

Chronic unpredictable stress (CUS) experiments were performed as described previously. Mice were exposed to a sequence of mild and unpredictable stressors for 14 d \[[@b12-en-28-537]\]. The 11 stressors used to generate the animal model of depression were as previously described \[[@b15-en-28-537]\]. For the chronic restraint stress (CRS) procedure, the mice were restrained horizontally in 50 ml conical centrifuge tubes drilled with holes to allow ample ventilation; the tubes were small enough to restrain the mice so that they were able to breathe but unable to move freely. The mice were stressed daily for 2 h for 14 d, and provided with food and water ad libitum \[[@b16-en-28-537]\].

Assessment of behavior
----------------------

On the test day, mice were placed to the testing room and acclimated to the room conditions for at least 1 h. Mice of the same cage were randomly assigned to different experimental groups for behavioral studies, and the order of testing was distributed across groups. All tests were conducted during the dark cycle. After each individual test session, the apparatus was thoroughly cleaned with 70% alcohol to eliminate any odor and trace of the previously tested mouse. Wherever possible, the experimenter conducting the data analysis was blind to the treatment conditions of the animals.

Locomotor activity test (LMA)
-----------------------------

Total locomotor activity was measured for 5 min with an ANY-maze video tracking system (Stoelting Co., IL, USA) in a plastic box (50×50×20 cm) and conducted as previously described \[[@b12-en-28-537]\].

Forced swim test (FST)
----------------------

FST was conducted as previously described. Mice were placed in a cylinder (height: 30 cm, diameter: 15 cm) filled with water at 24±1°C and a depth of 12 cm for 6 min. The immobility time in the last 4 min of the 6 min test period were measured \[[@b12-en-28-537]\].

Learned helplessness test (LHT)
-------------------------------

The learned helplessness procedure was based on previously described procedures. Mice were placed on a commercial shuttle box divided into two equal compartments by a central barrier (Gemini Avoidance System, San Diego Instruments) and then given inescapable footshocks (0.3 mA, 180 scrambled footshocks). The mean escape latency over 30 successive escape trials (0.3 mA, 25-sec maximum duration) was measured \[[@b12-en-28-537], [@b17-en-28-537]\].

Microarray dataset analysis
---------------------------

The following analyzing method was previously described \[[@b18-en-28-537]\]. The gene expression microarray dataset was obtained from the Gene Expression Omnibus (GEO, <http://www.ncbi.nlm.nih.gov/geo/>) with accession number GSE53987. It is described in detail in Lanz et al. (2015) \[[@b19-en-28-537]\]. Briefly, frozen sections of human brain were dissected to obtain tissue samples of hippocampus, Brodmann Area 46 and associative striatum. Total RNAs were isolated from the samples and microarray experiments were conducted with an Affymetrix platform (U133Plus-v2 Affymetrix whole genome microarray chips). The gene expression data were processed with Robust Multi-array Average (RMA). To identify genes differentially expressed in the hippocampi of controls and subjects with MDD, this study focused on a subset of the samples collected from the hippocampi; thus the samples were filtered to exclude samples of low quality (Brain pH≤6.5, RNA Integrity Number (RIN)≤6.0, Postmortem interval (PMI)\<24 hours). Next, the expression data were normalized by quantile normalization, and log2 transformed. Differentially expressed genes were identified using the LIMMA (Linear modeling of Microarray data) package \[[@b20-en-28-537]\]. Because of the small sample size, the usual statistical criteria used in microarray analysis (i.e., false discovery rate, FDR\<0.05) was not inappropriate for revealing differences between groups. Instead, p-values were used to obtain potentially interesting genes (p-value\<0.05). All data analyses and visualizations were conducted using R 3.4.3 ([www.r-project.org](www.r-project.org)).

Statistical analyses
--------------------

Data distributions were checked for normality and equal variance. All experiments were carried out at least three times, and data consistency was observed in repeated experiments. GraphPad Prism5.0 (GraphPad Software, Inc., La Jolla, CA, USA) was used for statistical analysis. p\<0.05 was considered statistically significant. Biochemical data are presented as means±s.e.m. of multiple independent experiments performed in triplicate.

RESULTS
=======

Chronic stress downregulates exprssions of ΔFosB and SIRT2 in the hippocampus of mice
-------------------------------------------------------------------------------------

SIRT2 expression is decreased in the blood of depressive-state MDD patients, and restored in the remissive state \[[@b5-en-28-537]\]. To examine the role of SIRT2 in the hippocampus following exposure to stress, we obtained mice that had been exposed to CUS or CRS for 2 weeks. We confirmed the reduced levels of SIRT2 in the hippocampus of the CUS ([Fig. 1A](#f1-en-28-537){ref-type="fig"}) and CRS ([Fig. 1B](#f1-en-28-537){ref-type="fig"}) models. Expression of delta FosB (ΔFosB), a transcription factor that is involved in stress \[[@b21-en-28-537]\] and known to directly regulate SIRT2 expression \[[@b22-en-28-537]\], was reduced in both depression models ([Fig. 1A and 1B](#f1-en-28-537){ref-type="fig"}). To investigate direct regulation by ΔFosB of the *Sirt2* promoter in the hippocampus, we performed ChIP assays on the hippocampi of mice subjected to stress. We found that enrichment of ΔFosB on the *Sirt2* promoter was significantly decreased in mice under CUS or CRS ([Fig. 1C and 1E](#f1-en-28-537){ref-type="fig"}), with a concomitant reduction of *Sirt2* mRNA in hippocampi ([Fig. 1D and 1F](#f1-en-28-537){ref-type="fig"}). Together, these results suggest that chronic stress downregulates SIRT2 expression possibly due to reduced ΔFosB in the hippocampus.

Expression of SIRT2 is decreased in the hippocampus in MDD
----------------------------------------------------------

To see if our results could be translated to human, we evaluated *SIRT2* mRNA levels in post-mortem hippocampal tissue in MDD patients. The gene expression dataset from GSE53987 was used to identify differences in gene expression in the hippocampus between patients with MDD and controls. Using the relevant sample selection criteria we performed gene expression analyses on a cohort of 14 hippocampus samples: 4 from patients with MDD and 10 from controls. As shown in [Fig. 1G](#f1-en-28-537){ref-type="fig"}, there were no significant differences in demographic characteristics between the subjects with MDD and the controls. *SIRT2* mRNA was significantly lower in the hippocampi of the MDD patients than in those of the controls ([Fig. 1H](#f1-en-28-537){ref-type="fig"}). No significant differences were observed for other SIRTs ([Fig. 1G](#f1-en-28-537){ref-type="fig"}). These results indicate that stress-induced down-regulation of SIRT2 may be associated with the development of depression.

Downregulation of SIRT2 reduces the expression of synaptic plasticity-related genes in primary hippocampal neurons
------------------------------------------------------------------------------------------------------------------

To investigate whether knockdown of SIRT2 affects expression of synaptic plasticity-related genes, we introduced lenti-shSIRT2 into hippocampal primary neurons to reduce SIRT2 expression. SIRT2 expression was markedly attenuated at both mRNA and protein levels ([Fig. 2A and 2D](#f2-en-28-537){ref-type="fig"}). ΔFosB is known to directly regulate SIRT2 expression but we also found that SIRT2 knockdown decreased expression of ΔFosB ([Fig. 2B and 2D](#f2-en-28-537){ref-type="fig"}). Early growth response protein 1 (Egr1) is thought to play a key role in inducing synaptic plasticity-related genes \[[@b23-en-28-537]\], and SIRT2 knockdown reduced the expression of Egr1 together with the pre-synaptic molecules, Synaptophysin and Synapsin1 ([Fig. 2C\~E](#f2-en-28-537){ref-type="fig"}). In addition, expression of glutamate receptor 1 (GluR1) was increased in lenti-shSIRT2 infected neurons compared to lenti-shLuc infected neurons ([Fig. 2E](#f2-en-28-537){ref-type="fig"}), consistent with an elevated level of GluR1 as a result of its increased stability due to reduced deacetylation by SIRT2 \[[@b24-en-28-537]\]. To see if a SIRT2 inhibition had similar effects to SIRT2 knockdown, we treated primary hippocampal neurons with AGK2 (5 μM, 72 h), an inhibitor of SIRT2, and found that expression levels of ΔFosB and pre-synaptic molecules including Synaptophysin and Synapsin1 were decreased, while that of Egr1 did not ([Fig. 2F\~I](#f2-en-28-537){ref-type="fig"}). Together, these results indicate that SIRT2 regulates the expression of transcription factors and pre-synaptic molecules that play important roles in resilience to stress.

SIRT2-mediated suppression of Ehmt2 increases presynaptic gene expression in hippocampal neurons
------------------------------------------------------------------------------------------------

It is well known that SIRT2 targets lysines in various cytosolic proteins \[[@b25-en-28-537]\]. However, we have focused on the function of SIRT2 in the nucleus, where transcriptional regulation occurs. SIRT2 is recruited to specific loci by co-repressor element-1 silencing transcription factor (CoREST) \[[@b26-en-28-537]\]. To study whether the inhibition of synaptic plasticity-related genes is regulated by SIRT2 knockdown, we first examined the association of SIRT2 with its corepressor and observed decreased association in primary hippocampal neurons infected with lenti-shSIRT2 compared to neurons infected with lenti-shLuc ([Fig. 3A](#f3-en-28-537){ref-type="fig"}). Given that SIRT2-CoREST corepressor complexes would inhibit the transcription of genes \[[@b26-en-28-537]\], we would expect that expression of SIRT2 target genes was increased in lenti-shSIRT2 infected neurons. We found that coimmunoprecipitation of SIRT2 and CoREST was reduced in neurons that were infected by lenti-shSIRT2 compared to neurons infected with lenti-shLuc ([Fig. 3A](#f3-en-28-537){ref-type="fig"}). CoREST binding to the promoter region of Ehmt2 and Scm Polycomb Group Protein Homolog 1 (Scmh1) was decreased in neurons infected by lenti-shSIRT2 ([Fig. 3B](#f3-en-28-537){ref-type="fig"}). Consistently, mRNA levels of Ehmt2 and Scmh1, two histone methyltransferases that targeted by SIRT2, were increased in primary hippocampal neurons infected with lenti-shSIRT2 compared to neurons infected with lenti-shLuc ([Fig. 3C and 3D](#f3-en-28-537){ref-type="fig"}), suggesting that SIRT2 negatively regulates the expression of Ehmt2 and Scmh1 although it is not clear whether this is a direct or indirect effect. Furthermore, H3K9me2, a known target of Ehmt2 and a marker of repressed gene repression, was enriched on the promoter regions of *Egr1*, *Synapsin1*, and *Synaptophysin* ([Fig. 3E](#f3-en-28-537){ref-type="fig"}), consistent with the reduced mRNA levels of *Egr1*, *Synapsin1*, and *Synaptophysin* ([Fig. 2C](#f2-en-28-537){ref-type="fig"}, [3F and 3G](#f3-en-28-537){ref-type="fig"}). Likewise, AGK2 induced the mRNA levels of Ehmt2 and Scmh1 along with a decrease of *Synaptophysin* mRNA ([Fig. 3H and 3J](#f3-en-28-537){ref-type="fig"}). Level of *Synapsin I* mRNA showed only a tendency to increase in response to AGK2 ([Fig. 3I](#f3-en-28-537){ref-type="fig"}). Collectively, these results suggest that SIRT2 attenuation lowers expression of synaptic plasticity-related genes, and this may, at least in part, contribute to depression-like behaviors.

Knockdown of SIRT2 in the DG induces depression-like behaviors in mice
----------------------------------------------------------------------

To demonstrate behavioral effects of SIRT2 knockdown, we infused lenti-shSIRT2 bilaterally into the hippocampal DG, which region is vulnerable to stress \[[@b27-en-28-537]\] ([Fig. 4A and 4B](#f4-en-28-537){ref-type="fig"}). SIRT2 expression was reduced at both the mRNA and protein level ([Fig. 4C and 4D](#f4-en-28-537){ref-type="fig"}). We then evaluated whether SIRT2 knockdown increased stress-induced behaviors, as indicated by reduced responsiveness in the FST and the LHT, two widely used models of behavioral despair. We found that immobility time and the latency to escape increased in the lenti-shSIRT2-infused mice ([Fig. 4F and 4G](#f4-en-28-537){ref-type="fig"}). There was no effect on spontaneous locomotor activity, including average speed, total distance travelled, and distance travelled from the center or margin, indicating that the effects in the FST were not due simply to inhibition of mobility ([Fig. 4E](#f4-en-28-537){ref-type="fig"}). Consistent with the *in vitro* experiments, levels of Egr1 and pre-synaptic molecules were reduced in the lenti-shSIRT2-infused DG. SIRT2 knockdown resulted in downregulation of ΔFosB *in vitro*, while ΔFosB was not affected in DG that infused with lenti-shSIRT2 ([Fig. 4H](#f4-en-28-537){ref-type="fig"}). The difference might be due to the age of neurons (embryonic versus adult), the environment (isolated versus intact) etc. Taken together, these results suggest that SIRT2 knockdown induces depression-like behaviors by downregulating synaptic plasticity-related genes.

DISCUSSION
==========

This study demonstrates that CUS downregulates SIRT2, resulting in an increase in the Ehmt2 which functions in the CoREST repressor complex. Ehmt2 targets the promoters of synaptic plasticity-related genes such as *Egr1*, *Synaptophysin* and *Synap-sin1*. These promoters are also marked by H3K9me2, leading to a reduction in transcript levels of genes. Collectively, SIRT2 knockdown in the DG results in depression-like behaviors in mice, accompanied by decreased expression of synaptic plasticity-related genes. These findings provide a molecular link between SIRT2 downregulation and impaired synaptic plasticity in the hippocampus of MDD patients. Therefore, SIRT2 expression may be of critical importance for maintaining synaptic plasticity and promoting resilience to stress.

Here, we show that H3K9me2, a marker of repressive genes, accumulates in the promoter regions of *Egr1*, *Synaptophysin*, and *Synapsin1*, which might be regulated via Ehmt2. In addition, Egr1 is a transcription factor that binds to the promoter regions of *Syn-apsin1* and *Synpatophysin*, which have Egr1-binding consensus sequences \[[@b28-en-28-537]\]. Therefore, downregulation of Egr1 might contribute to the reduced transcript levels of Synapsin1 and Synaptophysin. Taken together, these findings are in line with the previous suggestion that Egr1 positively regulates synaptic plasticity and neuropsychiatric disorders including stress-related mood disorders \[[@b23-en-28-537]\]. With regard to SIRT2 regulation of Ehmt2, we suggest the possibility that SIRT2 might be a key component to maintain CoREST-SIRT2 repressor complex for negatively regulating HMT promoters. Previous studies reported that stability of other CoR-EST repressor complex could be decreased by degradation/reduction of key component \[[@b29-en-28-537]\]. It would be worthwhile investigating whether downregulation by Ehmt2 would be sufficient to rescue the SIRT2 knockdown. In fact, Ehmt2 downregulation by Ehmt2 specific inhibitor reduced anxiety-like behaviors in mice \[[@b30-en-28-537]\]. We are currently investigating whether SIRT2 directly regulates Ehmt2 and the effects of Ehmt2 knockdown on animal model of depression.

According to previous reports, SIRT2 has a major role in modulating diverse biological mechanisms in the cytosol, including oxidative stress and inflammatory response in microglia cells associated with CNS disorders \[[@b2-en-28-537]\]. SIRT2 downregulation leads to cognitive impairment through aberrant post-translational modification of the AMPA receptor (AMPAR) in the CNS, which is directly related to depressive states \[[@b24-en-28-537], [@b31-en-28-537]\]. The function of SIRT2 in the nucleus is poorly understood; it appears to be a kind of histone deacetylase but its underlying role in depression is unclear. To the best of our knowledge, our findings constitute the first report that downregulation of SIRT2 produces depression-like behaviors via increased expression of histone methyltransferase that represses the promoter regions of synaptic plasticity-related genes in the hippocampus, and therefore, SIRT2 may be an attractive therapeutic target in major depressive disorder.
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![SIRT2 expression is decreased in the hippocampus of an animal model of depression and MDD patients. (A) Representative blots in hippocampus extracts (*left*). Quantification of the experiments showed decreased levels of ΔFosB and SIRT2 in the hippocampus of mice under CUS (*n*=3 per group) (*right*). (B) Representative blots of hippocampus extracts (*left*). Quantification showed decreased levels of ΔFosB and SIRT2 in the hippocampus of mice under CRS (*n*=3\~4 per group). (C) ChIP assays. Binding of ΔFosB to the *Sirt2* promoter was decreased in the hippocampus of mice under CUS (*n*=3 per group). (D) *Sirt2* and *β-actin* mRNA levels measured by qPCR in hippocampi of mice under CUS (*n*=3 per group). (E) ChIP assays. Binding of ΔFosB to the *Sirt2* promoter was decreased in the hippocampus of mice under CRS (*n*=3 per group). (F) *Sirt2* and *β-actin* mRNA levels were quantified by qPCR in hippocampus of mice under CRS (*n*=3 per group). (G) Microarray analysis (dataset accession number GSE53987) of post-mortem MDD hippocampal samples confirmed the reduction in SIRTs. (H) SIRT2 was down-regulated in post-mortem hippocampal tissue from subjects with MDD. Using appropriate sample selection criteria, we performed gene expression analyses on 14 hippocampus samples; 4 from patients with MDD and 10 controls. Data are mean±s.e.m. Unpaired *t* tests; \*p\<0.05, \*\*p\<0.01.](en-28-537-g001){#f1-en-28-537}

![Downregulation of SIRT2 decreases expression of synaptic plasticity-related genes in hippocampal neurons. (A) To assess the efficiency of lenti-shSIRT2, *Sirt2* and *β-actin* mRNA levels were quantified by qPCR (*n*=3). (B, C) Levels of Δ*FosB* and *Egr1* mRNAs in mouse hippocampal primary neurons were assayed by qPCR (*n*=3). (D) Western blot analysis showed that expression levels of SIRT2, ΔFosB, and Egr1 were decreased by lenti-shSIRT2 infection in hippocampal primary neurons (*n*=3). (E) lenti-shSIRT2 infection reduced protein levels of Synaptophysin (SYP) and Synapsin1 (Syn1) (*n*=3). (F\~I) The SIRT2-specific inhibitor, AGK2, (5 μm, 72 h) mimicked the effect of lenti-shSIRT2 infection in primary hippocampal neurons. (F, G) Levels of Δ*FosB* and *Egr1* mRNAs in mouse hippocampal primary neurons were assayed by qPCR (*n*=3). (H, I) Western blot analysis showed that expression levels of ΔFosB, Egr1, and pre-synaptic molecules were decreased by AGK2 treatment in hippocampal primary neurons (*n*=3\~4). Data are mean±s.e.m. Unpaired *t* tests; \*p\<0.05, \*\*p\<0.01.](en-28-537-g002){#f2-en-28-537}

![Downregulation of SIRT2 increases the levels of Ehmt2 and H3K9me2 at the promoters of presynaptic genes in hippocampal neurons. (A) Representative blots of SIRT2 and CoREST following immunoprecipitation of primary hippocampal neuron extracts (*left*). Protein levels were normalized to the abundance in SIRT2 input (*right*). Reduced SIRT2 binding to CoREST in lenti-shSIRT2 infected neurons (*n*=4). (B) ChIP assays. SIRT2 knockdown decreased the association of SIRT2-CoREST complexes with the *Ehmt2* and *Scmh1* promoters in hippocampal primary neurons (*n*=3). (C, D) Levels of *Ehmt2* and *Scmh1* mRNAs in mouse hippocampal primary neurons were assayed by qPCR (*n*=3). (E) ChIP assays. SIRT2 knockdown increased H3K9me2 levels of *Egr1*, *Synapsin1 (Syn1)* and *Synaptophysin (SYP)* promoters in hippocampal primary neurons (*n*=3). (F, G) *Synapsin1* and *Synaptophysin* mRNAs in the mouse hippocampal primary neurons were assayed by qPCR (*n*=3). (H) Effect of AGK2 treatment on levels of *Ehmt2* and *Scmh1* mRNAs in mouse hippocampal primary neurons was assayed by qPCR (*n*=3). (I, J) Effect of AGK2 treatment on levels of *Synapsin1* and *Synaptophysin* mRNAs in mouse hippocampal primary neurons was assayed by qPCR (*n*=3). Data are mean±s.e.m. Unpaired *t* tests; \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](en-28-537-g003){#f3-en-28-537}

![SIRT2 knockdown is accompanied by depression-like behaviors in mice. (A) The mouse U6 promoter was used to drive the expression of SIRT2-shRNA (*top*). Experimental design (*bottom*). (B) GFP staining confirmed localization of lentivirus in the DG. (Scale bar, 100 μm). (C) Mouse *Sirt2* and *β-actin* mRNA levels were quantified by qPCR (*n=*3 per group). (D) SIRT2 protein was quantified by Western blotting (*n*=3 per group). (E) LMA. Total distance, average speed, and distances travelled in the center or margin zone were scored at 5 min intervals (*n*=11, 10). (F) FST. Animals infused with lenti-shSIRT2 displayed depression-like behaviors compared with animals infused with lenti-shLuc (*n*=11, 11). (G) LHT. lenti-shSIRT2-infused mice had a longer latency to escape than animals infused with lenti-shLuc in trials 1--10 (*n*=10, 8). (H) Representative blots of DG lysates (*left*). Quantification of the results (*right*) (*n*=3). Data are means±s.e.m. Unpaired *t* tests; \*p\<0.05, \*\*p\<0.01.](en-28-537-g004){#f4-en-28-537}
